Press Releases from AOP Orphan Pharmaceuticals & Lantibio (1 total)
AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with No …
VIENNA, Austria and CHAPEL HILL, N.C., US, March 7 -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") and Lantibio, Inc. ("Lantibio") today announced positive final results…
Go To Page:
